Lowell Leow

Dr. Lowell Leow

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2021 in Journal of Artificial Organs
Verified
Journal Article
Closed access
PDF file
LLLowell Leow
Lowell Leow
HSHari Kumar Sampath
Hari Kumar Sampath
KYKeith J Yong
Keith J Yong
TKTheo Kofidis
Theo Kofidis
JTJohn Kit Chung Tam
John Kit Chung Tam
KRKollengode Ramanathan
Kollengode Ramanathan

8 January 2021 in Indian Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
KRKollengode Ramanathan
Kollengode Ramanathan
LLLowell Leow
Lowell Leow
HMHarish Mithiran
Harish Mithiran

9 April 2019 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
HMHarish Mithiran
Harish Mithiran
LLLowell Leow
Lowell Leow
KOKingsfield Ong
Kingsfield Ong
TLTerence Liew
Terence Liew
DSDaveraj Siva
Daveraj Siva
JTJohn Kit Chung Tam
John Kit Chung Tam

25 May 2021 in ASAIO Journal
Verified
Journal Article
Closed access
EPEvangelos Papadimas
Evangelos Papadimas
LLLowell Leow
Lowell Leow
Ying TanYing Tan
Ying Tan
LSLiang Shen
Liang Shen
KRKollengode Ramanathan
Kollengode Ramanathan
GMGraeme MacLaren
Graeme MacLaren
Extracorporeal membrane oxygenation (ECMO) is an invaluable means of supporting critically ill children with refractory respiratory or cardiac failure. Controversy remains; however, whether roller or centrifugal pumps are superior, particularly in infants. We performed a comprehensive search on PubMed, Embase, and Scopus for studies comparing the use of centrifugal and roller pumps in the pediatric and neonatal population from 1973 until March 1, 2020. All prospective and retrospective comparative studies were screened. Single-arm studies and those that included adult patients were excluded. The primary endpoint was survival to discharge. Secondary endpoints were complications (mechanical, cardiac, pulmonary, neurologic, renal, and hemolytic) and requirements for inotropic support. Random effects meta-analyses across all clinical endpoints were conducted. A total of four studies with 9111 patients were included. There was a statistically significant difference in in-hospital mortality, favoring the groups where roller pumps were used. Roller pumps were associated with fewer episodes of hemolysis, mechanical complications, cardiac complications, renal complications, and less inotropic support. ECMO with roller pumps may be associated with lower mortality in children. Roller pumps were associated with fewer complications, as well as reduced hemolysis and use of inotropes.

1 June 2021 in The Thoracic and Cardiovascular Surgeon
Verified
Journal Article
Closed access
PDF file
JNJosiah Ng
Josiah Ng
YMYoshio Masuda
Yoshio Masuda
JNJun Jie Ng
Jun Jie Ng
LLLowell Leow
Lowell Leow
ACAndrew M. T. L. Choong
Andrew M. T. L. Choong
HMHarish Mithiran
Harish Mithiran
Objectives We performed a systematic review and meta-analysis of outcomes of lobectomy versus sublobar resection in elderly patients (≥65) with stage 1 nonsmall cell lung carcinoma (NSCLC). Methods We searched for relevant articles using a set of inclusion and exclusion criteria. Meta-analytic techniques were applied. Results Twelve studies (n = 5834) were chosen. Our results indicate that in the elderly, lobectomy for stage 1 NSCLC confers a survival advantage over sublobar resection. Lobectomy patients had a lower risk of death within 5 years and lower odds of local cancer recurrence. Our results show that lobectomy had a better 5-year cancer-specific survival and 5-year disease-free survival that trended toward significance. The sublobar resection group showed better 30-day operative mortality that trended toward significance. Subgroup analysis of stage 1A cancer demonstrated no difference in 5-year overall survival rates. However, for stage 1B tumors 5-year overall survival favored lobectomy. Conclusion Lobectomy for stage 1 NSCLC in elderly patients is superior to sublobar resection in terms of survival and cancer recurrence and should be afforded where possible. For stage 1A tumors, sublobar resection is noninferior and may be considered. Further randomized controlled trials in this topic is required. Joint first-authors Josiah Ng and Yoshio Masuda are medical students who contributed equally to the inception, discussion, and drafting of this paper. They have contributed equally to the registration, literature review, data extraction, data processing, and revision of the paper under the guidance of the senior authors. Their joint authorship is approved by the senior author. * Joint first-authors. Received: 10 December 2020 Accepted: 29 January 2021 Publication Date: 01 June 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

1 February 2021 in The Surgeon
Verified
Journal Article
Closed access
LLLowell Leow
Lowell Leow
KRKollengode Ramanathan
Kollengode Ramanathan
TKTheo Kofidis
Theo Kofidis
JTJohn Kit Chung Tam
John Kit Chung Tam
HMHarish Mithiran
Harish Mithiran